Search Results - Riesco-Martínez, M

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Cost-effectiveness analysis of selective first-line use of biologics for unresectable RAS wild-type left-sided metastatic colorectal cancer

    Cost-effectiveness analysis of selective first-line use of biologics for unresectable RAS wild-type left-sided metastatic colorectal cancer by Wong, W W L, Zargar, M, Berry, S R, Ko, Y J, Riesco-Martínez, M, Chan, K K W

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Randomized phase II trial of FOLFIRI-panitumumab compared with FOLFIRI alone in patients with RAS wild-type circulating tumor DNA metastatic colorectal cancer beyond progression to first-line FOLFOX-panitumumab: the BEYOND study (GEMCAD 17-01)

    Randomized phase II trial of FOLFIRI-panitumumab compared with FOLFIRI alone in patients with RAS wild-type circulating tumor DNA metastatic colorectal cancer beyond progression to... by Aparicio, Jorge, Virgili Manrique, Anna C., Capdevila, Jaume, Muñoz Boza, Félix, Galván, Patricia, Richart, Paula, Oliveres, Helena, Páez, David, Hernando, Jorge, Serrano, Sara, Vera, Ruth, Hernandez-Yagüe, Xavier, Gallego, Rafael Álvarez, Riesco-Martinez, M. Carmen, García de Albeniz, Xavier, Maurel, Joan

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Bevacizumab in combination with biweekly capecitabine and irinotecan, as first-line treatment for patients with metastatic colorectal cancer

    Bevacizumab in combination with biweekly capecitabine and irinotecan, as first-line treatment for patients with metastatic colorectal cancer by García-Alfonso, P, Muñoz-Martin, A J, Alvarez-Suarez, S, Jerez-Gilarranz, Y, Riesco-Martinez, M, Khosravi, P, Martin, M

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Abstract P1-14-05: Is there a correlation between androgen receptor (AR) expression in metastatic breast cancer (MBC) ER+/Her2- and response to anti-estrogen treatment?

    Abstract P1-14-05: Is there a correlation between androgen receptor (AR) expression in metastatic breast cancer (MBC) ER+/Her2- and response to anti-estrogen treatment? by Riesco Martínez, MC, Hanna, W, Ghorab, Z, Warner, E

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Prognostic relevance of Src activation in stage II-III colon cancer

    Prognostic relevance of Src activation in stage II-III colon cancer by Perez, Julia Martinez, MD, Lopez-Calderero, Iker, MD, Saez, Carmen, PhD, Benavent, Marta, MD, Limon, Maria L., MD, Gonzalez-Exposito, Reyes, MD, Soldevilla, B., PhD, Riesco-Martinez, Maria C., MD, Salamanca, Javier, MD, Carnero, Amancio, PhD, Garcia-Carbonero, Rocio, MD, PhD

    Published in Human pathology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    A unique case of distant skin metastasis from chondroid chordoma

    A unique case of distant skin metastasis from chondroid chordoma by Riesco-Martínez, Maria C., Parrilla-Rubio, Lucía, Enguita-Valls, Ana B., Delgado-Márquez, Ana M., Ruste, Sherry A., López-Martín, Jose-A.

    Published in JAAD Case Reports
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    A unique case of distant skin metastasis from chondroid chordoma

    A unique case of distant skin metastasis from chondroid chordoma by Riesco-Martínez, Maria C, Parrilla-Rubio, Lucía, Enguita-Valls, Ana B, Delgado-Márquez, Ana M, Ruste, Sherry A, López-Martín, Jose-A

    Published in JAAD case reports
    Get full text
    Report
    Save to List
    Saved in:

Search Tools: